Tyson Foods Free cash flow increased by 178.2% to $690.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.2%, from $760.00M to $690.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.01B | $834.00M | $1.02B | $190.00M | $233.00M | $173.00M | -$501.00M | -$52.00M | $946.00M | $533.00M | $369.00M | $760.00M | $547.00M | $248.00M | $690.00M |
| QoQ Change | — | -17.0% | +22.8% | -81.4% | +22.6% | -25.8% | -389.6% | +89.6% | >999% | -43.7% | -30.8% | +106.0% | -28.0% | -54.7% | +178.2% |
| YoY Change | — | — | — | -81.1% | -72.1% | -83.1% | — | -122.3% | +446.8% | — | +809.6% | -19.7% | +2.6% | -32.8% | -9.2% |